← Open Payments lookup

LACY HOSAY: Open Payments

NPI 1538683636 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,325 in 77 payments from 20 companies in 2025. Trend: 2023 $2,361 · 2024 $1,517 · 2025 $1,325

Food & beverage: $1,325
CompanyPaymentsAmount
ABBVIE INC.34$532
AstraZeneca Pharmaceuticals LP9$162
Novo Nordisk Inc5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$97
Otsuka America Pharmaceutical, Inc.3$63
Amgen Inc.3$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$42
PFIZER INC.2$38
Lilly USA, LLC2$37
GlaxoSmithKline, LLC.2$32

Products named: VRAYLAR, UBRELVY, QULIPTA, CAPLYTA, AIRSUPRA, REXULTI, Wegovy, XIFAXAN.

Industry payments across MO — which companies pay providers there.